Abstract:Mouse models are commonly used for studying hepatocellular carcinoma (HCC) biology and exploring new therapeutic interventions. Currently three main modalities of HCC mouse models have been extensively employed in pre-clinical studies including chemically induced, transgenic and transplantation models. Among them, transplantation models are preferred for evaluating in vivo drug efficacy in pre-clinical settings given the short latency, uniformity in size and close resemblance to tumors in patients. However methods used for establishing orthotopic HCC transplantation mouse models are diverse and fragmentized without a comprehensive comparison. Here, we systemically evaluate four different approaches commonly used to establish HCC mice in preclinical studies, including intravenous, intrasplenic, intrahepatic inoculation of tumor cells and intrahepatic tissue implantation. Four parameters—the latency period, take rates, pathological features and metastatic rates—were evaluated side-by-side. 100% take rates were achieved in liver with intrahepatic, intrasplenic inoculation of tumor cells and intrahepatic tissue implantation. In contrast, no tumor in liver was observed with intravenous injection of tumor cells. Intrahepatic tissue implantation resulted in the shortest latency with 0.5cm (longitudinal diameter) tumors found in liver two weeks after implantation, compared to 0.1cm for intrahepatic inoculation of tumor cells. Approximately 0.1cm tumors were only visible at 4 weeks after intrasplenic inoculation. Uniform, focal and solitary tumors were formed with intrahepatic tissue implantation whereas multinodular, dispersed and non-uniform tumors produced with intrahepatic and intrasplenic inoculation of tumor cells. Notably, metastasis became visible in liver, peritoneum and mesenterium at 3 weeks post-implantation, and lung metastasis was visible after 7 weeks. T cell infiltration was evident in tumors, resembling the situation in HCC patients. Our study demonstrated that orthotopic HCC mouse models established via intrahepatic tissue implantation authentically reflect clinical manifestations in HCC patients pathologically and immunologically, suggesting intrahepatic tissue implantation is a preferable approach for establishing orthotopic HCC mouse models.

Construction of mouse model of liver implanted tumor after hepatectomy

Construction and Identification of BALB/c Mouse Liver Orthotopically Transplanted Cancer Model

Intrahepatic Tissue Implantation Represents a Favorable Approach for Establishing Orthotopic Transplantation Hepatocellular Carcinoma Mouse Models

A Nude Mouse Model of Orthotopic Liver Transplantation of Human Hepatocellular Carcinoma HCCLM3 Cell Xenografts and the Use of Imaging to Evaluate Tumor Progression

Establishment of a High Metastatic Potential Human Hepatocellular Carcinoma Orthotopic Transplantation Model with Palliative Liver Resection in Nude Mice

Establishment of a Metastatic Model of Human Hepatocellular Carcinoma in Nude Mice Via Orthotopic Implantation of Histologically Intact Tissues

The Establishment of Metastatic Human Hepatocellular Carcinoma Orthotopic Transplantation Model in Combination with Hepatic Artery Ligation in Nude Mice

TRANSPLANTATION OF HUMAN HEPATOCELLULAR CARCINOMA IN NUDE MICE I. ESTABLISHMENT OP MODEL AND ITS SEROLQGICAL AND MORPHOLOGICAL FEATURES

Metastatic Models of Human Liver Cancer in Nude Mice Orthotopically Constructed by Using Histologically Intact Patient Specimens

Establishment of an Insufficient Radiofrequency Ablation Orthotopic Nude Mouse Model of Hepatocellular Carcinoma to Study the Invasiveness and Metastatic Potential of Residual Cancer.

An Improved Model of Mouse Partial Hepatectomy for Study on Liver Regeneration

Metastatic Human Hepatocellular Carcinoma Models in Nude Mice and Cell Line with Metastatic Potential

The establishment of a systematic site-specific metastasis model of human hepatocellular carcinoma in nude mouse

Establishment of NOD/SCID Mouse Models of Human Hepatocellular Carcinoma Via Subcutaneous Transplantation of Histologically Intact Tumor Tissue.

Establishment of metastatic human hepatocellular carcinoma orthotopic transplantation model with palliative resection for investigating the biological characteristics of residual cancer in nude mice

[A Nude Mouse Model of Hepatocellular Carcinoma Single Cell-Derived Organ Site-Specific Metastasis].

Establishment of a H22 Implanted Advanced Hepatocellular Carcinoma Model of Mice

Establishment of image-guided radiotherapy of orthotopic hepatocellular carcinoma mouse model

Establishment of nude mice model with human hepatocellular carcinoma multidrug resistance exeografts

Establishment of an Orthotopic Transplantation Model of Human Hepatocellular Carcinoma in NOD-SCID Mice and Its Biological Characteristics

Liver cancer patient source heterotransplantation tumour mouse model and construction method thereof